Peri-Procedural Aggressive Hydration for Post Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis Prophylaxsis: Meta-analysis of Randomized Controlled Trials

Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]
Dhruvil RadadiyaChakradhar Reddy

Abstract

Periprocedural intravenous hydration is suggested to decrease the risk of post-ERCP pancreatitis (PEP). However, quality of evidence supporting this suggestion remains poor. Here we hypothesized that aggressive hydration(AH) could be an effective preventive measure. Pubmed, EMBASE, CINAHL, Google Scholar, Clinical Trials. gov, Clinical Key, International Standard Randomized Trial Number registry as well as secondary sources were searched through January 2019 to identify randomized controlled studies comparing AH to standard hydration (SH) for prevention of PEP. Pooled odds ratio (OR) and 95% confidence intervals (CIs) were calculated using the random-effects model. RevMan 5.3 was used for analysis. A total of 9 RCTs, with 2094 patients, were included in the meta-analysis. AH reduced incidence of PEP by 56% compared to SH (OR = 0.44, CI:0.28-0.69; p = 0.0004). The incidence of post-ERCP hyperamylasemia also decreased with AH compared to SH (OR = 0.51; p = 0.001). Length of stay decreased by 1 day with AH (Mean Difference (MD): -0.89 d; p = 0.00002). There was no significant difference in adverse events related to fluid overload between two groups (OR:1.29; p = 0.81) and post-ERCP abdominal pain (OR:0.35; p = 0.17). Numbers of pa...Continue Reading

References

May 1, 1991·Gastrointestinal Endoscopy·P B CottonN Nickl
Sep 26, 1996·The New England Journal of Medicine·M L FreemanA M Pheley
Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
Mar 10, 2001·The American Journal of Gastroenterology·E MasciP A Testoni
Sep 29, 2001·Journal of Clinical Epidemiology·J A Sterne, M Egger
Sep 29, 2001·Gastrointestinal Endoscopy·M L FreemanJ P Roel
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Jun 3, 2004·Gastrointestinal Endoscopy·Martin L Freeman, Nalini M Guda
Nov 24, 2004·Gastrointestinal Endoscopy·Merete ChristensenJacob Rosenberg
Jan 13, 2006·The American Journal of Gastroenterology·Chi-Liang ChengGlen A Lehman
Feb 27, 2007·Gastrointestinal Endoscopy·Young Koog CheonGlen A Lehman
May 19, 2007·The American Journal of Gastroenterology·Angelo AndriulliRosario Forlano
Dec 23, 2008·The American Journal of Gastroenterology·Peng WangFa-Chao Zhi
Mar 17, 2009·Gastrointestinal Endoscopy·Peter B CottonJoseph Romagnuolo
Jun 8, 2011·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Bechien U WuDarwin L Conwell
Aug 8, 2013·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·James BuxbaumLoren Laine
Jul 1, 2015·Internal Medicine Journal·N Maitin-CasalisA Thomson
Jun 18, 2016·Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association·Jun-Ho ChoiIl Han Song
Jul 23, 2016·Alimentary Pharmacology & Therapeutics·X J N M SmeetsE J M van Geenen
Aug 23, 2016·Gastrointestinal Endoscopy·UNKNOWN ASGE Standards of Practice CommitteeJohn M DeWitt

❮ Previous
Next ❯

Citations

Mar 20, 2021·The Lancet. Gastroenterology & Hepatology·Jeffrey J Easler, Evan L Fogel
Aug 7, 2021·Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [et Al.]·Katalin MártaPéter Hegyi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.